| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.881 | 0.004 | 0.887 | Caspase 9 stimulant | 0.887 0.004 CID_154699702 | CID_154699702 | |
| 0.773 | 0.005 | 0.773 | 12-Lipoxygenase inhibitor | |||
| 0.765 | 0.008 | 0.765 | 15-Lipoxygenase inhibitor | |||
| 0.751 | 0.007 | 0.751 | Aryl hydrocarbon receptor agonist | 0.238 0.084 CID_154699702 | ||
| 0.734 | 0.005 | 0.808 | Free radical scavenger | 0.808 0.004 CID_154699702 | CID_154699702 | |
| 0.739 | 0.024 | 0.767 | Apoptosis agonist | 0.767 0.021 CID_154699702 | CID_154699702 | |
| 0.718 | 0.007 | 0.718 | Aldehyde oxidase inhibitor | |||
| 0.712 | 0.002 | 0.712 | Cystathionine beta-synthase inhibitor | 0.654 0.003 CID_154699702 | ||
| 0.71 | 0.003 | 0.71 | Peroxidase inhibitor | 0.123 0.097 CID_154699702 | ||
| 0.694 | 0.006 | 0.833 | Antioxidant | 0.833 0.004 CID_154699702 | CID_154699702 | |
| 0.68 | 0.005 | 0.68 | Superoxide dismutase inhibitor | 0.181 0.14 CID_154699702 | ||
| 0.646 | 0.007 | 0.646 | Lipoxygenase inhibitor | |||
| 0.645 | 0.007 | 0.797 | Histamine release inhibitor | 0.797 0.003 CID_154699702 | CID_154699702 | |
| 0.674 | 0.038 | 0.893 | Alpha-glucosidase inhibitor | 0.893 0.008 CID_154699702 | CID_154699702 | |
| 0.624 | 0.006 | 0.65 | Hypoxia-inducible factor 1 alpha inhibitor | 0.65 0.005 CID_154699702 | CID_154699702 | |
| 0.612 | 0.003 | 0.612 | NADPH oxidase inhibitor | 0.603 0.004 CID_154699702 | ||
| 0.605 | 0.005 | 0.605 | MAO inhibitor | |||
| 0.608 | 0.01 | 0.712 | 5 Hydroxytryptamine release inhibitor | 0.712 0.004 CID_154699702 | CID_154699702 | |
| 0.577 | 0.004 | 0.577 | MAO A inhibitor | |||
| 0.572 | 0.012 | 0.572 | Caspase 3 stimulant | 0.525 0.017 CID_154699702 | ||
| 0.558 | 0.004 | 0.558 | Breast cancer-resistant protein inhibitor | 0.111 0.046 CID_154699702 | ||
| 0.573 | 0.035 | 0.802 | Transcription factor NF kappa B inhibitor | 0.802 0.013 CID_154699702 | CID_154699702 | |
| 0.546 | 0.01 | 0.546 | Amyloid beta aggregation inhibitor | 0.45 0.019 CID_154699702 | ||
| 0.531 | 0.007 | 0.531 | Pyruvate kinase inhibitor | 0.247 0.062 CID_154699702 | ||
| 0.543 | 0.021 | 0.543 | 5 Hydroxytryptamine release stimulant | 0.461 0.034 CID_154699702 | ||
| 0.534 | 0.018 | 0.534 | GABA C receptor rho-3 antagonist | |||
| 0.499 | 0.008 | 0.499 | P-glycoprotein inhibitor | 0.312 0.027 CID_154699702 | ||
| 0.489 | 0.003 | 0.489 | Carbonic anhydrase III inhibitor | 0.269 0.007 CID_154699702 | ||
| 0.485 | 0.002 | 0.485 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.131 0.025 CID_154699702 | ||
| 0.49 | 0.008 | 0.796 | Monophenol monooxygenase inhibitor | 0.796 0.003 CID_154699702 | CID_154699702 | |
| 0.516 | 0.039 | 0.516 | Prostaglandin dehydrogenase inhibitor | |||
| 0.489 | 0.017 | 0.858 | Vasodilator, coronary | 0.858 0.003 CID_154699702 | CID_154699702 | |
| 0.475 | 0.004 | 0.676 | Xanthine oxidase inhibitor | 0.676 0.003 CID_154699702 | CID_154699702 | |
| 0.471 | 0.004 | 0.471 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.346 0.013 CID_154699702 | ||
| 0.468 | 0.004 | 0.468 | Interleukin 4 antagonist | 0.252 0.013 CID_154699702 | ||
| 0.456 | 0.004 | 0.597 | Carbonic anhydrase XIII inhibitor | 0.597 0.003 CID_154699702 | CID_154699702 | |
| 0.456 | 0.005 | 0.544 | DNA methyltransferase I inhibitor | 0.544 0.004 CID_154699702 | CID_154699702 | |
| 0.467 | 0.025 | 0.467 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.449 | 0.007 | 0.764 | Amylase inhibitor | 0.764 0.002 CID_154699702 | CID_154699702 | |
| 0.462 | 0.025 | 0.621 | Apoptosis antagonist | 0.621 0.008 CID_154699702 | CID_154699702 | |
| 0.445 | 0.01 | 0.445 | Dual specificity phosphatase inhibitor | |||
| 0.433 | 0.004 | 0.433 | Carbonic anhydrase VI inhibitor | 0.212 0.012 CID_154699702 | ||
| 0.435 | 0.01 | 0.435 | Dual specificity phosphatase 3 inhibitor | |||
| 0.433 | 0.009 | 0.433 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.428 | 0.009 | 0.534 | DNA methylase inhibitor | 0.534 0.005 CID_154699702 | CID_154699702 | |
| 0.422 | 0.007 | 0.516 | Protein kinase stimulant | 0.516 0.004 CID_154699702 | CID_154699702 | |
| 0.418 | 0.007 | 0.418 | MAO B inhibitor | |||
| 0.421 | 0.011 | 0.654 | Non-steroidal antiinflammatory agent | 0.654 0.004 CID_154699702 | CID_154699702 | |
| 0.413 | 0.003 | 0.413 | Macrophage migration inhibitory factor inhibitor | |||
| 0.417 | 0.009 | 0.443 | Topoisomerase II inhibitor | 0.443 0.008 CID_154699702 | CID_154699702 | |
| 0.414 | 0.007 | 0.532 | NOS3 expression enhancer | 0.532 0.005 CID_154699702 | CID_154699702 | |
| 0.417 | 0.011 | 0.622 | Melanin inhibitor | 0.622 0.004 CID_154699702 | CID_154699702 | |
| 0.494 | 0.09 | 0.801 | Antiinflammatory | 0.801 0.015 CID_154699702 | CID_154699702 | |
| 0.415 | 0.016 | 0.415 | Transcription factor STAT inhibitor | |||
| 0.402 | 0.005 | 0.402 | Topoisomerase II alpha inhibitor | 0.373 0.005 CID_154699702 | ||
| 0.417 | 0.02 | 0.507 | Vasodilator | 0.507 0.011 CID_154699702 | CID_154699702 | |
| 0.407 | 0.012 | 0.407 | Tubulin antagonist | 0.111 0.09 CID_154699702 | ||
| 0.417 | 0.024 | 0.603 | Nitric oxide antagonist | 0.603 0.009 CID_154699702 | CID_154699702 | |
| 0.394 | 0.003 | 0.394 | Creatine kinase inhibitor | 0.103 0.056 CID_154699702 | ||
| 0.405 | 0.018 | 0.405 | RNA-directed DNA polymerase inhibitor | 0.288 0.034 CID_154699702 | ||
| 0.411 | 0.027 | 0.603 | Antiamyloidogenic | 0.603 0.008 CID_154699702 | CID_154699702 | |
| 0.399 | 0.027 | 0.596 | Tumour necrosis factor alpha release inhibitor | 0.596 0.008 CID_154699702 | CID_154699702 | |
| 0.409 | 0.038 | 0.642 | Spasmolytic | 0.642 0.009 CID_154699702 | CID_154699702 | |
| 0.377 | 0.011 | 0.47 | Lipid peroxidase inhibitor | 0.47 0.006 CID_154699702 | CID_154699702 | |
| 0.369 | 0.008 | 0.369 | Acetylcholinesterase inhibitor | 0.173 0.043 CID_154699702 | ||
| 0.386 | 0.031 | 0.538 | DNA damaging | 0.538 0.011 CID_154699702 | CID_154699702 | |
| 0.454 | 0.1 | 0.454 | DNA polymerase beta inhibitor | |||
| 0.381 | 0.031 | 0.721 | Hypoglycemic | 0.721 0.005 CID_154699702 | CID_154699702 | |
| 0.357 | 0.007 | 0.357 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.358 | 0.01 | 0.358 | Tumour necrosis factor antagonist | |||
| 0.341 | 0.005 | 0.405 | Nitric-oxide synthase stimulant | 0.405 0.003 CID_154699702 | CID_154699702 | |
| 0.336 | 0.014 | 0.336 | Protein-tyrosine phosphatase inhibitor | 0.255 0.03 CID_154699702 | ||
| 0.327 | 0.005 | 0.327 | Telomerase inhibitor | 0.063 0.061 CID_154699702 | ||
| 0.426 | 0.106 | 0.426 | DNA directed DNA polymerase inhibitor | |||
| 0.323 | 0.006 | 0.323 | Carbonic anhydrase XV inhibitor | |||
| 0.32 | 0.005 | 0.32 | Electron transport complex I inhibitor | 0.123 0.044 CID_154699702 | ||
| 0.324 | 0.009 | 0.499 | Alkaline phosphatase inhibitor | 0.499 0.004 CID_154699702 | CID_154699702 | |
| 0.327 | 0.012 | 0.327 | Amyloid beta precursor protein antagonist | |||
| 0.317 | 0.004 | 0.317 | Multidrug resistance-associated protein 1 inhibitor | 0.24 0.005 CID_154699702 | ||
| 0.316 | 0.008 | 0.316 | Succinate dehydrogenase inhibitor | 0.154 0.105 CID_154699702 | ||
| 0.323 | 0.024 | 0.586 | Hepatoprotectant | 0.586 0.005 CID_154699702 | CID_154699702 | |
| 0.355 | 0.06 | 0.355 | Streptokinase A inhibitor | |||
| 0.356 | 0.071 | 0.356 | Thyroid hormone antagonist | |||
| 0.373 | 0.089 | 0.69 | Antibacterial | 0.69 0.009 CID_154699702 | CID_154699702 | |
| 0.295 | 0.011 | 0.295 | 5-Lipoxygenase inhibitor | |||
| 0.298 | 0.018 | 0.298 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.312 | 0.041 | 0.312 | Antimitotic | |||
| 0.341 | 0.072 | 0.341 | Thyroid hormone beta antagonist | |||
| 0.283 | 0.017 | 0.283 | Cytokine production inhibitor | |||
| 0.284 | 0.021 | 0.284 | Cholinergic | 0.116 0.113 CID_154699702 | ||
| 0.264 | 0.004 | 0.264 | Xanthine dehydrogenase inhibitor | 0.113 0.013 CID_154699702 | ||
| 0.265 | 0.009 | 0.265 | GABA C receptor rho-2 antagonist | |||
| 0.334 | 0.081 | 0.334 | Vasodilator, peripheral | 0.259 0.121 CID_154699702 | ||
| 0.299 | 0.05 | 0.299 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.298 | 0.05 | 0.74 | Angiogenesis stimulant | 0.74 0.004 CID_154699702 | CID_154699702 | |
| 0.253 | 0.006 | 0.253 | HIV-1 integrase (3'-Processing) inhibitor | 0.106 0.024 CID_154699702 | ||
| 0.298 | 0.054 | 0.298 | Transcription factor STAT3 inhibitor | |||
| 0.246 | 0.006 | 0.367 | Photosensitizer | 0.367 0.003 CID_154699702 | CID_154699702 | |
| 0.268 | 0.029 | 0.28 | Neurotrophic factor enhancer | 0.28 0.024 CID_154699702 | CID_154699702 | |
| 0.279 | 0.045 | 0.279 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.236 | 0.003 | 0.236 | D-Ala-D-Ala ligase inhibitor | |||
| 0.313 | 0.08 | 0.748 | Antithrombotic | 0.748 0.006 CID_154699702 | CID_154699702 | |
| 0.236 | 0.003 | 0.236 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.176 0.005 CID_154699702 | ||
| 0.247 | 0.015 | 0.247 | Butyrylcholinesterase inhibitor | |||
| 0.247 | 0.016 | 0.247 | Protein kinase (CK2) alpha inhibitor | |||
| 0.234 | 0.007 | 0.234 | HIV-1 integrase (Strand Transfer) inhibitor | 0.093 0.025 CID_154699702 | ||
| 0.243 | 0.017 | 0.243 | Chelator | 0.108 0.066 CID_154699702 | ||
| 0.244 | 0.022 | 0.244 | Heat shock protein 90 antagonist | |||
| 0.226 | 0.005 | 0.226 | Histone deacetylase SIRT1 stimulant | 0.175 0.006 CID_154699702 | ||
| 0.226 | 0.005 | 0.226 | Histone deacetylase stimulant | 0.175 0.006 CID_154699702 | ||
| 0.229 | 0.008 | 0.229 | Estrogen receptor beta antagonist | |||
| 0.226 | 0.006 | 0.238 | Aldose reductase inhibitor | 0.238 0.005 CID_154699702 | CID_154699702 | |
| 0.238 | 0.019 | 0.238 | Protein-tyrosine phosphatase 1B inhibitor | 0.214 0.025 CID_154699702 | ||
| 0.246 | 0.028 | 0.246 | Heat shock protein 90 alpha antagonist | |||
| 0.263 | 0.045 | 0.44 | Platelet adhesion inhibitor | 0.44 0.008 CID_154699702 | CID_154699702 | |
| 0.224 | 0.01 | 0.224 | Estrogen antagonist | 0.114 0.067 CID_154699702 | ||
| 0.216 | 0.005 | 0.216 | Heat shock protein 70 antagonist | 0.205 0.005 CID_154699702 | ||
| 0.272 | 0.063 | 0.272 | Dyrk kinase inhibitor | |||
| 0.245 | 0.038 | 0.245 | Mcl-1 antagonist | |||
| 0.214 | 0.008 | 0.214 | Aromatase inhibitor | |||
| 0.219 | 0.016 | 0.219 | Toll-Like receptor 2 antagonist | 0.107 0.094 CID_154699702 | ||
| 0.214 | 0.011 | 0.214 | Uric acid excretion stimulant | 0.204 0.013 CID_154699702 | ||
| 0.31 | 0.109 | 0.519 | Immunosuppressant | 0.519 0.028 CID_154699702 | CID_154699702 | |
| 0.22 | 0.021 | 0.231 | Mannose-6-phosphate isomerase inhibitor | 0.231 0.017 CID_154699702 | CID_154699702 | |
| 0.22 | 0.023 | 0.228 | Aldehyde dehydrogenase inhibitor | 0.228 0.022 CID_154699702 | CID_154699702 | |
| 0.202 | 0.006 | 0.202 | CDC25A inhibitor | 0.082 0.041 CID_154699702 | ||
| 0.203 | 0.011 | 0.203 | Protein kinase C zeta inhibitor | |||
| 0.192 | 0.005 | 0.192 | Myeloperoxidase inhibitor | |||
| 0.225 | 0.039 | 0.225 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.229 | 0.048 | 0.229 | Insulin sensitizer | 0.216 0.058 CID_154699702 | ||
| 0.211 | 0.03 | 0.211 | Cyclooxygenase 1 inhibitor | 0.155 0.054 CID_154699702 | ||
| 0.199 | 0.019 | 0.535 | Cyclooxygenase 3 inhibitor | 0.535 0.003 CID_154699702 | CID_154699702 | |
| 0.204 | 0.025 | 0.316 | Topoisomerase I inhibitor | 0.316 0.01 CID_154699702 | CID_154699702 | |
| 0.214 | 0.036 | 0.214 | Cyclooxygenase inhibitor | 0.214 0.036 CID_154699702 | ||
| 0.181 | 0.005 | 0.181 | Carbonic anhydrase VII inhibitor | 0.109 0.009 CID_154699702 | ||
| 0.189 | 0.014 | 0.196 | Alcohol dehydrogenase inhibitor | 0.196 0.013 CID_154699702 | CID_154699702 | |
| 0.18 | 0.005 | 0.18 | CD45 antagonist | |||
| 0.189 | 0.014 | 0.592 | Beta glucuronidase inhibitor | 0.592 0.003 CID_154699702 | CID_154699702 | |
| 0.18 | 0.009 | 0.18 | Carbonic anhydrase V inhibitor | |||
| 0.202 | 0.031 | 0.202 | Arachidonic acid antagonist | 0.13 0.113 CID_154699702 | ||
| 0.259 | 0.088 | 0.259 | Insulysin inhibitor | |||
| 0.19 | 0.021 | 0.19 | Protein kinase (CK2) inhibitor | |||
| 0.2 | 0.036 | 0.292 | Insulin secretagoues | 0.292 0.013 CID_154699702 | CID_154699702 | |
| 0.173 | 0.017 | 0.394 | AMP-activated protein kinase stimulant | 0.394 0.004 CID_154699702 | CID_154699702 | |
| 0.163 | 0.008 | 0.163 | Carbonic anhydrase VA inhibitor | |||
| 0.168 | 0.014 | 0.168 | Transcription factor STAT6 inhibitor | |||
| 0.157 | 0.005 | 0.157 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.159 | 0.008 | 0.159 | Thioredoxin reductase inhibitor | 0.088 0.045 CID_154699702 | ||
| 0.161 | 0.01 | 0.161 | Estrogen receptor alpha antagonist | |||
| 0.168 | 0.018 | 0.357 | DNA repair enzyme inhibitor | 0.357 0.004 CID_154699702 | CID_154699702 | |
| 0.154 | 0.005 | 0.154 | Aryl hydrocarbon receptor antagonist | |||
| 0.188 | 0.039 | 0.188 | Bone formation stimulant | 0.142 0.065 CID_154699702 | ||
| 0.165 | 0.017 | 0.165 | Urease inhibitor | |||
| 0.156 | 0.009 | 0.171 | T cell inhibitor | 0.171 0.009 CID_154699702 | CID_154699702 | |
| 0.194 | 0.048 | 0.194 | Phospholipase C inhibitor | 0.164 0.081 CID_154699702 | ||
| 0.206 | 0.06 | 0.206 | Histone acetyltransferase inhibitor | |||
| 0.27 | 0.124 | 0.27 | Calcium channel activator | |||
| 0.161 | 0.016 | 0.161 | DOPA decarboxylase inhibitor | |||
| 0.181 | 0.037 | 0.188 | Cyclooxygenase 2 inhibitor | 0.188 0.034 CID_154699702 | CID_154699702 | |
| 0.147 | 0.003 | 0.147 | Glutamate (mGluR7) antagonist | 0.062 0.058 CID_154699702 | ||
| 0.153 | 0.012 | 0.153 | Beta tubulin antagonist | |||
| 0.295 | 0.157 | 0.295 | Transcription factor inhibitor | |||
| 0.145 | 0.007 | 0.145 | CDC25B inhibitor | |||
| 0.257 | 0.12 | 0.509 | Cholesterol antagonist | 0.509 0.031 CID_154699702 | CID_154699702 | |
| 0.219 | 0.083 | 0.219 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.183 | 0.049 | 0.346 | Interferon gamma antagonist | 0.346 0.014 CID_154699702 | CID_154699702 | |
| 0.159 | 0.026 | 0.159 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.156 | 0.023 | 0.156 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.134 | 0.005 | 0.134 | Potassium channel Kv1.3 blocker | |||
| 0.146 | 0.017 | 0.146 | CYP2A6 inhibitor | |||
| 0.129 | 0.003 | 0.129 | Ryanodine receptor antagonist | 0.056 0.052 CID_154699702 | ||
| 0.135 | 0.011 | 0.135 | Alpha tubulin antagonist | |||
| 0.128 | 0.005 | 0.128 | Fatty acid synthase inhibitor | 0.069 0.027 CID_154699702 | ||
| 0.151 | 0.028 | 0.151 | Potassium channel (Ca-activated) activator | |||
| 0.196 | 0.074 | 0.196 | I kappa B kinase epsilon inhibitor | |||
| 0.153 | 0.031 | 0.153 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.124 | 0.003 | 0.124 | Dopamine D5 agonist | |||
| 0.288 | 0.168 | 0.288 | Calcium channel L-type activator | |||
| 0.143 | 0.025 | 0.143 | Calcium antagonist | |||
| 0.123 | 0.007 | 0.187 | Carbonic anhydrase XIV inhibitor | 0.187 0.004 CID_154699702 | CID_154699702 | |
| 0.128 | 0.013 | 0.128 | HIV-1 integrase inhibitor | 0.063 0.06 CID_154699702 | ||
| 0.126 | 0.012 | 0.126 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.16 | 0.048 | 0.16 | Adenylate cyclase stimulant | |||
| 0.12 | 0.009 | 0.12 | Protease activated receptor antagonist | |||
| 0.138 | 0.027 | 0.138 | GABA C receptor rho-1 antagonist | |||
| 0.127 | 0.019 | 0.127 | Cyclin B3 inhibitor | |||
| 0.138 | 0.03 | 0.138 | Sphingomyelinase inhibitor | 0.115 0.045 CID_154699702 | ||
| 0.294 | 0.187 | 0.294 | MAP kinase 1 inhibitor | |||
| 0.143 | 0.037 | 0.161 | Mucolytic | 0.161 0.027 CID_154699702 | CID_154699702 | |
| 0.13 | 0.025 | 0.158 | Thioredoxin inhibitor | 0.158 0.015 CID_154699702 | CID_154699702 | |
| 0.116 | 0.014 | 0.116 | Estrogen agonist | 0.093 0.019 CID_154699702 | ||
| 0.14 | 0.039 | 0.452 | Expectorant | 0.452 0.004 CID_154699702 | CID_154699702 | |
| 0.123 | 0.027 | 0.123 | Phosphodiesterase 4D inhibitor | |||
| 0.12 | 0.024 | 0.12 | Interleukin 5 antagonist | 0.115 0.027 CID_154699702 | ||
| 0.13 | 0.034 | 0.182 | Toll-Like receptor 4 antagonist | 0.182 0.009 CID_154699702 | CID_154699702 | |
| 0.105 | 0.009 | 0.105 | Heat shock protein 90 beta antagonist | |||
| 0.099 | 0.007 | 0.099 | Transcription factor RelA inhibitor | |||
| 0.124 | 0.031 | 0.124 | Androgen antagonist | |||
| 0.141 | 0.052 | 0.289 | Alkylator | 0.289 0.013 CID_154699702 | CID_154699702 | |
| 0.107 | 0.019 | 0.107 | Leukotriene antagonist | 0.083 0.03 CID_154699702 | ||
| 0.209 | 0.121 | 0.209 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.152 | 0.065 | 0.477 | Hemostatic | 0.477 0.005 CID_154699702 | CID_154699702 | |
| 0.145 | 0.057 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.14 0.075 CID_154699702 | ||
| 0.109 | 0.024 | 0.109 | mTOR complex 2 inhibitor | |||
| 0.173 | 0.092 | 0.173 | Anesthetic general | 0.169 0.095 CID_154699702 | ||
| 0.13 | 0.048 | 0.13 | TRPA1 agonist | |||
| 0.125 | 0.043 | 0.338 | Mediator release inhibitor | 0.338 0.006 CID_154699702 | CID_154699702 | |
| 0.133 | 0.055 | 0.133 | Cholesterol synthesis inhibitor | 0.1 0.087 CID_154699702 | ||
| 0.177 | 0.098 | 0.177 | Interleukin antagonist | |||
| 0.09 | 0.013 | 0.09 | Estrogen receptor beta agonist | 0.032 0.023 CID_154699702 | ||
| 0.1 | 0.024 | 0.1 | Potassium channel large-conductance Ca-activated activator | |||
| 0.115 | 0.04 | 0.262 | Antineoplastic antibiotic | 0.262 0.013 CID_154699702 | CID_154699702 | |
| 0.093 | 0.021 | 0.206 | Carbonic anhydrase XII inhibitor | 0.206 0.008 CID_154699702 | CID_154699702 | |
| 0.183 | 0.111 | 0.183 | ErbB-1 antagonist | |||
| 0.098 | 0.027 | 0.098 | Estrogen-related receptor beta agonist | |||
| 0.101 | 0.03 | 0.101 | Keratolytic | |||
| 0.149 | 0.078 | 0.149 | CF transmembrane conductance regulator agonist | |||
| 0.097 | 0.028 | 0.097 | Leukotriene synthesis inhibitor | |||
| 0.096 | 0.029 | 0.096 | Lipase inhibitor | |||
| 0.157 | 0.09 | 0.157 | Death-associated protein kinase 2 inhibitor | |||
| 0.12 | 0.055 | 0.12 | Nav1.5 sodium channel blocker | |||
| 0.077 | 0.014 | 0.077 | Topoisomerase II beta inhibitor | 0.066 0.018 CID_154699702 | ||
| 0.222 | 0.159 | 0.222 | Sodium/bile acid cotransporter inhibitor | |||
| 0.117 | 0.054 | 0.118 | Acetylcholine release stimulant | 0.118 0.051 CID_154699702 | CID_154699702 | |
| 0.117 | 0.055 | 0.117 | GABA C receptor antagonist | |||
| 0.104 | 0.042 | 0.104 | Phosphodiesterase IV inhibitor | |||
| 0.095 | 0.034 | 0.095 | Caspase 7 inhibitor | |||
| 0.065 | 0.005 | 0.065 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.163 | 0.105 | 0.201 | Psychostimulant | 0.201 0.08 CID_154699702 | CID_154699702 | |
| 0.096 | 0.038 | 0.096 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.104 | 0.046 | 0.104 | ABCA1 expression enhancer | |||
| 0.09 | 0.032 | 0.09 | Adenosine A3 receptor antagonist | |||
| 0.101 | 0.043 | 0.101 | Ornithine decarboxylase inhibitor | |||
| 0.1 | 0.043 | 0.176 | NADH dehydrogenase inhibitor | 0.176 0.013 CID_154699702 | CID_154699702 | |
| 0.153 | 0.097 | 0.291 | ATPase inhibitor | 0.291 0.007 CID_154699702 | CID_154699702 | |
| 0.105 | 0.051 | 0.105 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.103 | 0.049 | 0.199 | Interleukin 12 antagonist | 0.199 0.005 CID_154699702 | CID_154699702 | |
| 0.114 | 0.061 | 0.173 | DNA intercalator | 0.173 0.034 CID_154699702 | CID_154699702 | |
| 0.089 | 0.037 | 0.089 | Histidine decarboxylase inhibitor | |||
| 0.151 | 0.099 | 0.151 | Neurotensin receptor agonist | |||
| 0.138 | 0.088 | 0.138 | Phospholipase A2 inhibitor | |||
| 0.076 | 0.026 | 0.076 | Beta 3 adrenoreceptor antagonist | |||
| 0.054 | 0.006 | 0.054 | Vanilloid 3 antagonist | |||
| 0.06 | 0.012 | 0.06 | GABA B receptor antagonist | |||
| 0.117 | 0.07 | 0.152 | Beta amyloid protein antagonist | 0.152 0.039 CID_154699702 | CID_154699702 | |
| 0.067 | 0.021 | 0.099 | Leukotriene B4 antagonist | 0.099 0.01 CID_154699702 | CID_154699702 | |
| 0.064 | 0.018 | 0.064 | CXC chemokine 1 receptor antagonist | |||
| 0.073 | 0.027 | 0.073 | Protein kinase C eta inhibitor | |||
| 0.057 | 0.012 | 0.057 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.059 | 0.015 | 0.059 | Estrogen receptor alpha agonist | |||
| 0.071 | 0.027 | 0.071 | Carbonic anhydrase VB inhibitor | |||
| 0.168 | 0.125 | 0.345 | Cyclic AMP phosphodiesterase inhibitor | 0.345 0.027 CID_154699702 | CID_154699702 | |
| 0.064 | 0.022 | 0.064 | Leukotriene C antagonist | |||
| 0.102 | 0.06 | 0.102 | Anabolic | |||
| 0.058 | 0.016 | 0.058 | DNA-dependent protein kinase inhibitor | |||
| 0.05 | 0.009 | 0.05 | Catechol O-methyltransferase inhibitor | |||
| 0.062 | 0.021 | 0.112 | Glucose-6-phosphate translocase inhibitor | 0.112 0.005 CID_154699702 | CID_154699702 | |
| 0.053 | 0.012 | 0.053 | Sirtuin 2 inhibitor | |||
| 0.13 | 0.091 | 0.13 | Cytidine deaminase inhibitor | |||
| 0.096 | 0.057 | 0.096 | Bile acid receptor antagonist | |||
| 0.122 | 0.084 | 0.122 | Toll-Like receptor 9 antagonist | |||
| 0.185 | 0.147 | 0.347 | DNA synthesis inhibitor | 0.347 0.031 CID_154699702 | CID_154699702 | |
| 0.07 | 0.032 | 0.07 | Purinergic P2X1 antagonist | |||
| 0.067 | 0.031 | 0.067 | Alcohol oxidase inhibitor | |||
| 0.073 | 0.037 | 0.073 | Dopamine D1 antagonist | |||
| 0.044 | 0.009 | 0.044 | Protein kinase (CK2) beta inhibitor | |||
| 0.078 | 0.044 | 0.113 | Phosphodiesterase VI inhibitor | 0.113 0.014 CID_154699702 | CID_154699702 | |
| 0.049 | 0.015 | 0.049 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.109 | 0.076 | 0.152 | Microtubule formation inhibitor | 0.152 0.037 CID_154699702 | CID_154699702 | |
| 0.065 | 0.035 | 0.065 | CDK4/cyclin D1 inhibitor | |||
| 0.097 | 0.067 | 0.097 | Bronchodilator | |||
| 0.052 | 0.023 | 0.052 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.201 | 0.172 | 0.201 | Thioredoxin glutathione reductase inhibitor | |||
| 0.09 | 0.061 | 0.1 | Glutamate release inhibitor | 0.1 0.042 CID_154699702 | CID_154699702 | |
| 0.055 | 0.026 | 0.055 | Squalene epoxidase inhibitor | |||
| 0.062 | 0.035 | 0.062 | Sphingosine kinase inhibitor | |||
| 0.13 | 0.103 | 0.246 | Hexokinase inhibitor | 0.246 0.018 CID_154699702 | CID_154699702 | |
| 0.079 | 0.052 | 0.122 | Na+ K+ transporting ATPase inhibitor | 0.122 0.015 CID_154699702 | CID_154699702 | |
| 0.094 | 0.068 | 0.198 | UDP-glucose 4-epimerase inhibitor | 0.198 0.018 CID_154699702 | CID_154699702 | |
| 0.051 | 0.026 | 0.051 | Adenylate cyclase 1 inhibitor | |||
| 0.057 | 0.033 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.063 | 0.04 | 0.092 | Neuraminidase inhibitor | 0.092 0.019 CID_154699702 | CID_154699702 | |
| 0.036 | 0.015 | 0.036 | Estrogen-related receptor beta antagonist | |||
| 0.131 | 0.11 | 0.131 | MAP kinase kinase 4 inhibitor | |||
| 0.104 | 0.083 | 0.104 | Proteasome inhibitor | |||
| 0.08 | 0.061 | 0.08 | Glutathione S-transferase inhibitor | |||
| 0.066 | 0.048 | 0.066 | Glutamate (mGluR6) antagonist | |||
| 0.077 | 0.06 | 0.077 | Phosphodiesterase 3A inhibitor | |||
| 0.091 | 0.074 | 0.132 | Phosphodiesterase 6D inhibitor | 0.132 0.017 CID_154699702 | CID_154699702 | |
| 0.039 | 0.023 | 0.084 | Arginase inhibitor | 0.084 0.005 CID_154699702 | CID_154699702 | |
| 0.053 | 0.038 | 0.179 | Heparanase inhibitor | 0.179 0.002 CID_154699702 | CID_154699702 | |
| 0.075 | 0.061 | 0.075 | MAP kinase kinase 7 inhibitor | |||
| 0.035 | 0.02 | 0.035 | Melatonin 2 agonist | |||
| 0.115 | 0.101 | 0.115 | Vanilloid 1 agonist | |||
| 0.109 | 0.095 | 0.109 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.053 | 0.041 | 0.053 | DNA helicase inhibitor | |||
| 0.062 | 0.05 | 0.098 | Neuraminidase (influenza) inhibitor | 0.098 0.017 CID_154699702 | CID_154699702 | |
| 0.062 | 0.051 | 0.062 | Beta adrenoreceptor antagonist | |||
| 0.024 | 0.013 | 0.024 | Estrone sulfatase inhibitor | |||
| 0.119 | 0.107 | 0.119 | Farnesoid X receptor antagonist | |||
| 0.04 | 0.03 | 0.04 | Liver X receptor alpha agonist | |||
| 0.024 | 0.014 | 0.024 | Dopamine D1 agonist | 0.021 0.019 CID_154699702 | ||
| 0.038 | 0.029 | 0.038 | Leukotriene C4 antagonist | |||
| 0.051 | 0.042 | 0.071 | Maillard reaction inhibitor | 0.071 0.028 CID_154699702 | CID_154699702 | |
| 0.033 | 0.024 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.104 | 0.096 | 0.193 | Alpha-N-acetylglucosaminidase inhibitor | 0.193 0.036 CID_154699702 | CID_154699702 | |
| 0.164 | 0.156 | 0.164 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.04 | 0.032 | 0.04 | Dopamine D5 antagonist | |||
| 0.031 | 0.024 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.056 | 0.049 | 0.075 | Carbonic anhydrase inhibitor | 0.075 0.037 CID_154699702 | CID_154699702 | |
| 0.024 | 0.017 | 0.024 | Dopamine autoreceptor agonist | |||
| 0.054 | 0.048 | 0.054 | Pregnane X receptor antagonist | |||
| 0.049 | 0.043 | 0.077 | Carbonic anhydrase IX inhibitor | 0.077 0.028 CID_154699702 | CID_154699702 | |
| 0.071 | 0.065 | 0.071 | GABA B receptor agonist | |||
| 0.019 | 0.013 | 0.032 | Antibiotic Anthracycline-like | 0.032 0.003 CID_154699702 | CID_154699702 | |
| 0.069 | 0.064 | 0.069 | GABA aminotransferase inhibitor | |||
| 0.074 | 0.069 | 0.074 | Opioid kappa receptor antagonist | |||
| 0.089 | 0.085 | 0.089 | Glutamate (mGluR7) agonist | |||
| 0.012 | 0.009 | 0.012 | Melatonin 2 antagonist | |||
| 0.063 | 0.06 | 0.063 | Phosphodiesterase V inhibitor | |||
| 0.082 | 0.079 | 0.082 | Pim-1 kinase inhibitor | |||
| 0.12 | 0.118 | 0.12 | Thiol protease inhibitor | |||
| 0.084 | 0.082 | 0.084 | Alpha 2c adrenoreceptor antagonist | |||
| 0.022 | 0.02 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.022 | 0.03 | 0.096 | Sodium/glucose cotransporter 2 inhibitor | 0.096 0.003 CID_154699702 | CID_154699702 | |
| 0.074 | 0.088 | 0.142 | Triose-phosphate isomerase inhibitor | 0.142 0.022 CID_154699702 | CID_154699702 | |
| 0.224 | 0.243 | 0.769 | Cyclophilin D inhibitor | 0.769 0.008 CID_154699702 | CID_154699702 | |
| 0.02 | 0.041 | 0.078 | Sodium/glucose cotransporter inhibitor | 0.078 0.004 CID_154699702 | CID_154699702 | |
| 0.038 | 0.061 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.024 CID_154699702 | CID_154699702 | |
| 0.061 | 0.092 | 0.087 | Interferon agonist | 0.087 0.042 CID_154699702 | CID_154699702 | |
| 0.071 | 0.104 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 CID_154699702 | CID_154699702 | |
| 0.048 | 0.082 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 CID_154699702 | CID_154699702 | |
| 0.014 | 0.054 | 0.055 | Protein 30S ribosomal subunit inhibitor | 0.055 0.007 CID_154699702 | CID_154699702 | |
| 0.099 | 0.139 | 0.289 | Diuretic | 0.289 0.024 CID_154699702 | CID_154699702 | |
| 0.068 | 0.109 | 0.094 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.094 0.06 CID_154699702 | CID_154699702 | |
| 0.041 | 0.085 | 0.1 | Phosphofructokinase-1 inhibitor | 0.1 0.032 CID_154699702 | CID_154699702 | |
| 0.128 | 0.173 | 0.345 | Platelet antagonist | 0.345 0.039 CID_154699702 | CID_154699702 | |
| 0.039 | 0.086 | 0.055 | Factor III inhibitor | 0.055 0.024 CID_154699702 | CID_154699702 | |
| 0.128 | 0.177 | 0.496 | Immunostimulant | 0.496 0.03 CID_154699702 | CID_154699702 | |
| 0.035 | 0.093 | 0.049 | Cytokine production stimulant | 0.049 0.032 CID_154699702 | CID_154699702 | |
| 0.028 | 0.087 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 CID_154699702 | CID_154699702 | |
| 0.005 | 0.065 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 CID_154699702 | CID_154699702 | |
| 0.064 | 0.127 | 0.141 | Transcription factor NF kappa B stimulant | 0.141 0.018 CID_154699702 | CID_154699702 | |
| 0.055 | 0.13 | 0.152 | Falcipain 2 inhibitor | 0.152 0.028 CID_154699702 | CID_154699702 | |
| 0.056 | 0.135 | 0.155 | Falcipain inhibitor | 0.155 0.029 CID_154699702 | CID_154699702 | |
| 0.03 | 0.11 | 0.072 | Alpha-mannosidase inhibitor | 0.072 0.015 CID_154699702 | CID_154699702 | |
| 0.04 | 0.123 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 CID_154699702 | CID_154699702 | |
| 0.022 | 0.106 | 0.075 | Antibiotic Aminoglycoside-like | 0.075 0.005 CID_154699702 | CID_154699702 | |
| 0.103 | 0.192 | 0.19 | Interleukin 6 antagonist | 0.19 0.047 CID_154699702 | CID_154699702 | |
| 0.02 | 0.12 | 0.064 | Mannosidase inhibitor | 0.064 0.015 CID_154699702 | CID_154699702 | |
| 0.107 | 0.211 | 0.143 | CC chemokine 6 receptor antagonist | 0.143 0.033 CID_154699702 | CID_154699702 | |
| 0.029 | 0.134 | 0.07 | Nitric oxide donor | 0.07 0.033 CID_154699702 | CID_154699702 | |
| 0.059 | 0.167 | 0.123 | DNA polymerase I inhibitor | 0.123 0.066 CID_154699702 | CID_154699702 | |
| 0.041 | 0.17 | 0.073 | Glycine receptor antagonist | 0.073 0.069 CID_154699702 | CID_154699702 | |
| 0.022 | 0.151 | 0.045 | Microtubule stabilization | 0.045 0.034 CID_154699702 | CID_154699702 | |
| 0.128 | 0.273 | 0.187 | Angiogenesis inhibitor | 0.187 0.185 CID_154699702 | CID_154699702 | |
| 0.019 | 0.169 | 0.1 | Protein 50S ribosomal subunit inhibitor | 0.1 0.013 CID_154699702 | CID_154699702 | |
| 0.015 | 0.196 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699702 | CID_154699702 | |
| 0.067 | 0.248 | 0.215 | Cell wall synthesis inhibitor | 0.215 0.025 CID_154699702 | CID_154699702 | |
| 0.075 | 0.26 | 0.236 | Interleukin agonist | 0.236 0.09 CID_154699702 | CID_154699702 | |
| 0.048 | 0.243 | 0.32 | Thrombolytic | 0.32 0.021 CID_154699702 | CID_154699702 | |
| 0.07 | 0.285 | 0.282 | Hypolipemic | 0.282 0.055 CID_154699702 | CID_154699702 | |
| 0.018 | 0.293 | 0.076 | DNA gyrase inhibitor | 0.076 0.03 CID_154699702 | CID_154699702 | |
| 0.011 | 0.329 | 0.329 | Selectin antagonist | 0.329 0.004 CID_154699702 | CID_154699702 | |
| 0.091 | 0.502 | 0.361 | Peptidyltransferase inhibitor | 0.361 0.01 CID_154699702 | CID_154699702 | |
| 0.094 | 0.511 | 0.372 | Interleukin 2 agonist | 0.372 0.037 CID_154699702 | CID_154699702 | |
| 0.015 | 0.573 | 0.057 | Factor IXa inhibitor | 0.057 0.029 CID_154699702 | CID_154699702 | |
| 0.021 | 0.588 | 0.219 | Cell adhesion inhibitor | 0.219 0.02 CID_154699702 | CID_154699702 | |
| 0.013 | 0.636 | 0.18 | Anticoagulant | 0.18 0.061 CID_154699702 | CID_154699702 | |
| 0.009 | 0.668 | 0.079 | Cell adhesion molecule inhibitor | 0.079 0.054 CID_154699702 | CID_154699702 | |
| 0.033 | 0.693 | 0.371 | Immunomodulator | 0.371 0.053 CID_154699702 | CID_154699702 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |